Project Grant HT94252310156

Award Date 9/1/23
Completion Date 8/31/27
Dollars Obligated $1.5M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This federal Project Grant award from the Department of Defense's Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,605,000.00 to Baylor College of Medicine to conduct research on genetically dissecting neural circuits underlying anorexia nervosa. The 4-year project, running from September 1, 2023, to August 31, 2027, aims to advance scientific understanding of the neurological mechanisms driving this complex eating disorder. As a...
The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
The Defense Health Agency awarded a $4.23 million Project Grant to the University of Kansas Center for Research Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420) to assess eating disorder and comorbidity risk and resilience in a nationally representative sample of recent military enlistees from April 15, 2023 to April 14, 2027. The University of Kansas will lead the research effort to test the performance of a new eating disorder assessment measure in...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $669,421.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on the long-term impact of deployment exposures on neuropathy of brainstem pathways, associated symptoms, and health measures in veterans with Gulf War Illness. The research will be performed over a two-year period from September 30, 2024 to...
The Department of Defense awarded a $748,784 Project Grant to the University of Texas Health Science Center at Houston (UTHealth) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, will support research to detect and characterize alpha-synuclein aggregates in patients with Alzheimer's disease and related dementias. Through this project, UTHealth, the prime grantee, will conduct specialized laboratory testing, data...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $451,000.00 to the University of Texas Southwestern Medical Center to conduct research on "DISSECTING BIOLOGICAL MECHANISMS UNDERLYING BEHAVIORAL HETEROGENEITY IN AUTISM" from April 1, 2024 to March 31, 2027. The research aims to advance scientific understanding of the biological basis for the variability in autism spectrum disorder symptoms and...
The University of Texas Health Science Center at Houston (UTHealth) received a $777,586 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 30, 2024 to September 29, 2027, will fund the "Stress Inoculation Training (SIT): An Evidence-Driven, Military-Aligned Psychological Performance and Health Sustainment Prototype" research project. The project...
This Project Grant award, valued at $999,784.00, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports advanced biomedical research conducted by Texas A&M University System Health Science Center to investigate circadian dysregulation as a risk factor for age-related cognitive impairment. This research aims to transform healthcare for military service members and the broader public...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...

This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,547,864.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on genetically dissecting the neural circuits underlying anorexia nervosa. The research aims to advance scientific understanding and develop new treatment approaches for this condition, which disproportionately impacts military service members and veterans. As a subrecipient, the University of Texas System will also contribute specialized expertise and capabilities to support aspects of the research initiative. This multi-year award, with a period of performance from September 1, 2023 to August 31, 2027, leverages UTHealth's extensive capabilities in neuroscience, public health, and biomedical research to address an important military health priority.

Generated 8/13/24, 7:33 AM